Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis

Summary

The Sponsor is developing the study drug, AZD0284, for the potential treatment of Plaque psoriasis. Psoriasis is a skin condition that causes red, flaky, crusty patches of skin covered with silvery scales. The severity of the disease varies, but in many cases it can have a major impact on their quality of life if not adequately treated. The purpose of the study is to determine the short term safety, pharmacodynamic and clinical effect of AZD0284 in patients with psoriasis.

Timeline

Start

2017-11-29

Primary completion

2018-04-18

Completion

2018-04-18

Outcome

Outcome not reported

Stopped: “The study is temporarily suspended due to preclinical findings that are currently under evaluation”

Drugs

Indications